6IQG | date | ![]() |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | |||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | |||||||||||||
ligand | BMA, CL, FUC, HCS, MAN, NAG | enzyme |
| ||||||||||||
Primary reference | Site-specific chemical conjugation of antibodies by using affinity peptide for the development of therapeutic antibody format., Kishimoto S, Nakashimada Y, Yokota R, Hatanaka T, Adachi M, Ito Y, Bioconjug Chem. 2019 Jan 4. doi: 10.1021/acs.bioconjchem.8b00865. PMID:30606013 |
Data retrieval |
![]() |
View 6IQG in 3D |
![]() |
Structure-derived information |
Sequence-derived information |
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |